7 results
Anti-IL6 Agents (Tocilizumab, Siltuximab) in COVID19

IL-6 activates T cells and macrophages, among other cell types (see
Anti-IL6 Agents ... other cell types (see ... Cytokine Activation Syndrome ... Siltuximab #COVID19 #Pharmacology ... #Management #Medications
Macrophage Activation Syndrome (MAS)
Classified among the secondary or acquired forms of haemophagocytic lymphohistiocytosis (sHLH)

What?
A subset of
develops on the background ... Clinical Presentation ... Fever is the main clinical ... erythematosus [SLE ... #Diagnosis #Management
Pain, Agitation, and Delirium (PAD) in the ICU
Addressing the ICU Triad (PAD) can be accomplished through
will vary with clinical ... Propofol infusion syndrome ... non-OTC prolonging agent ... No pharmacologic ... CriticalCare #diagnosis #management
Antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis
Fluconazole
 - Benefits: Low cost/tolerable
Antifungal agents ... prolongation, alopecia ... Weaknesses: Limited clinical ... Coccidioidomycosis #pharmacology ... #management #treatment
Overview of antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis.
Fluconazole - Low
of antifungal agents ... prolongation, alopecia ... tolerable • Limited clinical ... #valleyfever #management ... comparison #table #pharmacology
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
Sjogren's Syndrome ... overlaps with RA, SLE ... salivary ducts Clinical ... lubricants • Pharmacologic ... Rheumatology #Diagnosis #Management
Mermaid Syndrome

Doctors at the Petlaburj Maternity Hospital in Hyderabad delivered a rare 'mermaid baby' or a
died due to a critical ... The child's parents ... been told that she ... But she beat all ... #clinical #photo